Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022:1385:23-73.
doi: 10.1007/978-3-031-08356-3_2.

Circulating MicroRNAs as Cancer Biomarkers in Liquid Biopsies

Beatriz Suárez #  1 , Carla Solé #  1 , Maitane Márquez  1 , Francesca Nanetti  1 , Charles Henderson Lawrie  2   3   4   5
Affiliations
Review

Circulating MicroRNAs as Cancer Biomarkers in Liquid Biopsies

Beatriz Suárez et al. Adv Exp Med Biol. 2022.

Abstract

Biological fluids such as blood, saliva, and urine offer a rich source of biomarkers that have the potential to change the paradigm of cancer management. By allowing routine noninvasive sampling that can offer new insights into cancer progression and response to treatment so-called liquid biopsies can play an important role in personalized medicine. MicroRNAs (miRNAs) are a particularly attractive class of biomarkers as they are not only resistant to the high levels of RNases found in biological fluids, but also able to confer clinically useful information about the disease relating to diagnosis, prognosis, and the response to treatment. Circulating miRNAs are either associated with proteins or extracellular vesicles (EV) and although their origin and implied functions as intracellular messengers remain somewhat controversial, they are implicated in the progression and the establishment of metastatic niches. In this chapter, we review the rapidly emerging field of circulating miRNA cancer biomarkers, their origin and function, techniques to detect these molecules, and the use of bioinformatic tools to derive implied regulatory function, as well as the challenges that lie ahead for their clinical implementation.

Keywords: Bioinformatics; Biomarkers; Cancer; Liquid biopsy; miRNAs; ncRNAs.

PubMed Disclaimer

References

    1. Aad G, Abbott B, Abdallah J, Abdelalim AA, Abdesselam A, Abdinov O et al (2010) Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett 105(16):161801 - PubMed
    1. Afshar S, Afshar S, Warden E, Manochehri H, Saidijam M (2019) Application of artificial neural network in miRNA biomarker selection and precise diagnosis of colorectal cancer. Int J Mol Sci 23(3):175–183
    1. Agarwal V, Bell GW, Nam JW, Bartel DP (2015) Predicting effective microRNA target sites in mammalian mRNAs. elife 4
    1. Aguda BD, Kim Y, Piper-Hunter MG, Friedman A, Marsh CB (2008) MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proc Natl Acad Sci U S A 105(50):19678–19683 - PubMed - PMC
    1. Akers JC, Gonda D, Kim R, Carter BS, Chen CC (2013) Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neuro-Oncol 113(1):1–11

LinkOut - more resources